Survey measures outsourcing highs, lows; Reese gets FDA warning;

> Survey: 55 percent of biopharma organizations outsource less than half of their global manufacturing, but 18 percent use outsourcing for at least 91 percent of their output. Release

> Over-the-counter drugmaker Reese Pharmaceutical has received an FDA warning letter for manufacturing and labeling violations. Story

> Capgemini: The pharmaceutical industry needs to address patient adherence in a more strategic and integrated part of its activities. Statement

> Systech International and Videojet say they are working with a big pharma manufacturer to implement Systech's Serialized Product Tracking solution on each of its packaging lines in Brazil.  Release

> German transdermal drug developer Labtec has opened a manufacturing facility in Europe for the production of transdermal drug delivery systems and oral dispersible films using its RapidFilm technology. Story

> CMO Lonza is planning a "state-of-the-art" GMP cleanroom for its viral-based therapeutics business in Houston, Texas. Report

> Sun Pharma says it will invest $100 million to expand and upgrade Taro Pharma's facilities. Item

> Schott has opened a primary pharmaceutical packaging facility in Zavolzhe, Russia. News

Suggested Articles

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S. 

After months of delay for ultra-pricey gene therapy Zynteglo, Bluebird Bio is hoping to dose its first German patients in the first half of the year.

North Carolina is providing some financial assistance for the construction of Audentes gene therapy facility in Sanford, North Carolina. (Astellas)